Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therapeutics 40 (12) (2018) 2077-2087].
Providence Multiple Sclerosis Center, Portland, OR, USA.
Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA.
USF Multiple Sclerosis Center, Tampa, FL, USA.
Biogen, Cambridge, MA, USA.
Biogen, Cambridge, MA, USA. Electronic address: [email protected]
- Published Article
- Publication Date
Dec 01, 2019
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 12/31/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31255296